The agreement revolves around providing and maintaining supply chain transparency.
Systech, a provider of digital identification and traceability solutionsfor the pharma industry, was selected by Praxis Packaging Solutions to provide a track-and-trace platform for supply chain transparency.1 This partnership grants Praxis customers access to aggregation and product tracing services that are able to meet global compliance requirements, such as the FDA’s Drug Supply Chain Security Act (DSCSA), which has a November 2024 enforcement deadline.
The provider will leverage its branded UniSeries suite for Levels 1-3. Alongside serialization services, the system features Systech’s UniTrace Level 4 platform, a turnkey aggregation and rework station as well as Systech Insight, which has the capability of providing real-time performance monitoring.
“We are excited to expand our partnership with Systech beyond serialization,” said Sarah Faison, senior director of sales and marketing at Praxis. “Given Systech’s rich history and expertise in packaging execution and traceability, we look forward to leveraging their out-of-the-box, proven systems to better serve our customers with cutting-edge compliance and supply chain solutions.”
Executives at Systech are also relishing this opportunity.
“This strategic partnership will provide superior end-to-end visibility and best-in-class track and trace for Praxis’s customer base,” noted Sreedhar Patnala, general manager of Systech. “It is a testament to our commitment to providing comprehensive, future-proof solutions to the pharma industry.”
Reference
1. Systech selected by Praxis Packaging for track and trace solutions. Systech. News release. July 16, 2024. Accessed July 18, 2024. https://www.systechone.com/systech-selected-by-praxis-packaging-for-track-and-trace-solutions/
Is Compounding the Answer to the Semaglutide Shortage? Experts Weigh In
October 30th 2024In this Q&A, Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss the challenges faced by patients and healthcare providers due to drug shortages, particularly for semaglutide and other medications.